Bill of Health
NOVEMBER 29, 2023
As the patent approaches expiration, the brand licenses to generics. The central message here is that recurrent structures manifest in the pharmaceutical industry, and those structures can be informative to foresee future patterns. But, the company spends lots of money to destigmatize the drug, and sales improve.
Bill of Health
MAY 5, 2023
To solve this tension, the Commission recognizes that patent law already offers a solution: compulsory licensing. The Proposal A compulsory license allows third parties to use a patent without asking prior permission from the owner of said patent. The powers to grant such a license will be in the hands of the Commission.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bill of Health
AUGUST 29, 2022
These pledges can take a variety of forms and have been made for decades in industries ranging from automotive (e.g., After the pandemic, it is willing to offer paid licenses. Licensing structures like this go back at least to World War II, when the U.S. First, a pledge like Moderna’s acts as a “ public license.”
Healthcare IT Today
DECEMBER 27, 2022
“A $320 million global industry in 2021 projected to reach $640 million* by 2025, the rising number of cancer cases and the demonstrated benefits of digital pathology are fueling significant demand and market growth in the hospital and pharmaceutical industries,” says Henry Izawa, president and CEO at FUJIFILM Healthcare Americas Corporation.
Bill of Health
SEPTEMBER 28, 2023
Senator Sanders’ proposal within PAHPA was ultimately struck from the next iteration of the legislation due to concerns from the pharmaceutical industry and others that such a measure would chill innovation. Federal support by BARDA and the CDC have de-risked the development of medical products for the pharmaceutical industry.
Verisys
FEBRUARY 7, 2024
The more you know about the people in your organization, the safer you are from risks that could damage your company, your reputation, or your compliance.The regulations in the pharmaceutical industry are understandably strict, and to ensure your organization is compliant, every member of your team must be thoroughly vetted.
Healthcare IT Today
JANUARY 23, 2024
global lead of the Accenture Life Sciences business, said, “Through our investment in QuantHealth, we are further solidifying our commitment to utilizing advanced technologies to bring revolutionary change in the pharmaceutical industry. Petra Jantzer, Ph.D.,
Expert insights. Personalized for you.
260 
Let's personalize your content